These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 26805365)

  • 1. [Treating Side Effects of FOLFIRINOX--A Study of the Effect of Hange-Shashin-To on Preventing Diarrhea].
    Hoshi N; Kofunato Y; Yashima R; Shimura T; Takenoshita S
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2364-6. PubMed ID: 26805365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kampo medicines for the prevention of irinotecan-induced diarrhea in advanced non-small cell lung cancer].
    Mori K; Hirose T; Machida S; Tominaga K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1159-63. PubMed ID: 9679578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hange-Shashin-to for preventing diarrhea during afatinib therapy].
    Yamaguchi O; Kawashima A; Shiono A; Maeno Y; Ishikawa R; Masumoto A; Utsugi H; Daito H; Okano T; Murayama Y; Kobayashi K
    Gan To Kagaku Ryoho; 2015 May; 42(5):581-3. PubMed ID: 25981651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer].
    Hibi S; Ina K; Furuta R; Kataoka T; Kojima S; Kawai M
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1485-8. PubMed ID: 19755817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [FOLFIRINOX Combination Chemotherapy in Patients with Metastatic or Recurrent Pancreatic Cancer--A Single Institution Experience].
    Takeda Y; Katsura Y; Ohmura Y; Morimoto Y; Ishida T; Motoyama Y; Ohneda Y; Sato Y; Kuwahara R; Murakami K; Naito A; Kagawa Y; Okishiro M; Takeno A; Egawa C; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2360-3. PubMed ID: 26805364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preventive effect of TJ-14, a kampo (Chinese herb) medicine, on diarrhea induced by irinotecan hydrochloride (CPT-11)].
    Sakata Y; Suzuki H; Kamataki T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1241-4. PubMed ID: 8031168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Ingredients of Hange-shashin-to, Baicalelin and 6-Gingerol, Inhibit 5-Fluorouracil-Induced Upregulation of CXCL1 in the Colon to Attenuate Diarrhea Development.
    Sakai H; Tabata S; Kimura M; Yabe S; Isa Y; Kai Y; Sato F; Yumoto T; Miyano K; Narita M; Uezono Y
    Biol Pharm Bull; 2017; 40(12):2134-2139. PubMed ID: 29199237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hange-shashin-to raises levels of somatostatin, motilin, and gastrin in the plasma of healthy subjects.
    Naito T; Itoh H; Yasunaga F; Takeyama M
    Biol Pharm Bull; 2002 Mar; 25(3):327-31. PubMed ID: 11913527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effects of Hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat.
    Kase Y; Hayakawa T; Aburada M; Komatsu Y; Kamataki T
    Jpn J Pharmacol; 1997 Dec; 75(4):407-13. PubMed ID: 9469647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of pancreatic cancer treated with FOLFIRINOX regimen and G-CSF prophylaxis at the standard therapeutic dose].
    Kiba T; Okada Y; Kajiume S; Yamaguchi A
    Gan To Kagaku Ryoho; 2015 May; 42(5):629-32. PubMed ID: 25981661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Treatment Outcomes of FOLFIRINOX for Unresectable and Recurrent Pancreatic Cancer].
    Sakamoto T; Takeda Y; Ohmura Y; Katsura Y; Mori R; Nose Y; Kawai K; Murakami K; Naito A; Inatome J; Kagawa Y; Masuzawa T; Takeno A; Egawa C; Murata K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1751-1753. PubMed ID: 29394764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on antidiarrheal effects of Hange-shashin-to.
    Kase Y; Hayakawa T; Takeda S; Ishige A; Aburada M; Okada M
    Biol Pharm Bull; 1996 Oct; 19(10):1367-70. PubMed ID: 8913514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of second-line treatment with capecitabine and thalidomide in patients with advanced pancreatic cancer].
    Shi SB; Ma TH; Tang XY; Li CH
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):301-4. PubMed ID: 23985261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of hange-shashin-to and rikkunshi-to on human plasma calcitonin gene-related peptide and substance P levels.
    Naito T; Itoh H; Takeyama M
    Biol Pharm Bull; 2003 Aug; 26(8):1104-7. PubMed ID: 12913259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 study.
    Hirata K; Nagata N; Kato T; Okuyama Y; Andoh H; Takahashi K; Oba K; Sakamoto J; Hazama S; Mishima H
    Anticancer Res; 2014 Jan; 34(1):195-201. PubMed ID: 24403462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some gastrointestinal function regulatory Kampo medicines have modulatory effects on human plasma adrenocorticotropic hormone and cortisol levels with continual stress exposure.
    Naito T; Itoh H; Takeyama M
    Biol Pharm Bull; 2003 Jan; 26(1):101-4. PubMed ID: 12520183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Brain Metastases from Pancreatic Cancer That Had Been Treated Effectively with FOLFIRINOX].
    Miura T; Nakamura N; Kurihara Y; Yonekura K; Watanabe Y; Sanada T; Kuwabara H; Goseki N
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2357-9. PubMed ID: 26805363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study of Chinese herbal medicinal prescription with enzyme inhibitory activity. V. The study of hange-shashin-to, kanzo-shashin-to, shokyo-shashin-to with adenosine 3',5'-cyclic monophosphate phosphodiesterase].
    Suzuki M; Nikaido T; Ohmoto T
    Yakugaku Zasshi; 1991 Nov; 111(11):695-701. PubMed ID: 1664464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
    Tsujie M; Nakamori S; Tanaka E; Nagano H; Umeshita K; Dono K; Sakon M; Inoue T; Inoue T; Monden M
    Jpn J Clin Oncol; 2006 Aug; 36(8):504-10. PubMed ID: 16855011
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.